10 Minute point-of-care FDA EUA Authorized Rapid

Natures Body Wellness™ is a licensed & insured healthcare supply chain manufacturer & distributor delivering premium medical diagnostic research, tests and services worldwide. We now perform independent validations and clinical studies for SARS-CoV-2 in-vitro
diagnostic testing kits across a wide array of testing modalities and can assist manufactures receive CE or FDA EUA status.

 Hospitals and Laboratories working with NBW receive critical and streamlined access to research, data and time sensitive resources as well as shipment of the kits to absolutely anywhere in the world. 
We independently verify every test we sell and many more that we don’t. We also possess special partner agreements with other manufacturers and large scale distributors which enhances cross-selling verticals for our clients. Our raw material buying power, global reach and high capacity production capabilities creates a win-win partnership for our clients. NBW is also known for publishing The Antibody Testing Guideline for Employers Workplace & Employees utilizing CDC, EEOC, OSHA. & ADA directives.

Click the contact button below to buy or speak with someone in detail about your needs.

Nutraceuticals – NBW Possesses an advanced background in Pharmaceutical Consulting & Plant Based Formulations with core competencies in Hemp, Mesenchymal stem cell exosomes,  & Weight Loss.

FDA EUA Authorized IgM/IgG Antibody Rapid Test

This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. 

The Fastep COVID-19 IgG/IgM Rapid Test Device by Assure Tech. is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum or plasma. The test is for professional use only.

Warnings

  • This product is intended for professional use and not for home use.
  • Not for the screening of donated blood.

Consultation to Businesses & Healthcare Providers
Back to Work & Stay at work Employer Programs.

We sell to high complexity laboratories and certain healthcare providers. We do not sell to the general public.

whologo_optimized-e1597843109956.jpg
nhilogo_optimized-e1597842815431.jpg

This information is intended for physicians and healthcare professionals only. Product registration and availability vary by country. For more information on product availability, please contact us here.

The Assure Fastep test kit has not been FDA cleared or approved; This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. 

Dual Antibody Combination Testing Kits

Biohit Antibody Rapid Test Kit

Backed by Clinical Trials

healgenkit3-1.png

Healgen Antibody Rapid Test Kit

Accurate Antibody Results in as quickly as 2 minutes.

Assure Fastep COVID-19 IgG and IgM Rapid Test Kit

Performance Results from Clinical Studies

Authorized for fingerstick use only in-patient care settings operating under a CLIA Certificates of Waiver, Compliance, or Accreditation. This product can only be sold to healthcare facilities, practitioners, institution or qualified research or screening organizations. 

Testing is not for home use and is intended to be administered by a trained healthcare professional.

We will contact you to verify your healthcare provider credentials prior to shipping. Please do not order this product if you are not a licensed healthcare provider or laboratory.

Virus Testing Methodologies

Millenia Advanced Scientific

Screen-Shot-2020-09-03-at-6.08.14-PM.png
Testing for proteins from the virus surface
Nasopharyngeal Swab Collection
How it works: Antigen tests can identify virus in nose and throat secretions. It does this by looking for proteins from the virus surface (as opposed to PCR  which looks for genetic material). This is the same technology used in doctor’s offices for rapid strep testing.
Active Infection: Detectable when a person is infected.

PCR (Polymerase Chain Reaction) Test Kit

Screen-Shot-2020-09-03-at-6.08.35-PM.png
Testing for genetic material of the virus.
Nasopharyngeal Swab Collection

How it works: This test uses a sample of mucus typically taken from a person’s nose, throat or saliva. It looks for the genetic material of the virus. The test uses a technology called PCR (polymerase chain reaction), which greatly amplifies the viral genetic material if it is present.
Active Infection: Detectable when a person is infected.

Workplace Programs

Workplace Testing Programs are an ongoing battle field to get your employees back to work sooner and safely. We have implemented many programs and can have Nuclear and Antigen Testing done on large scale in 24 hours. Results same day.

The Most Comprehensive Corporate Testing Program

Antibody Tests

Antibody tests are typically only authorized for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. EUA tests are only authorized for the duration of the decleration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b) (1) of the Act, 21 U.S.C. $360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Sales Professionals

Call 855-752-6879

Please complete the form so that we can approve your wholesale account and provide a customized quote for you